The role of interferons type I, II and III in myositis: A review-Reference-Cited by-同舟云学术

The role of interferons type I, II and III in myositis: A review

Published:2021-05 Issue:3 Volume:31 Page:
ISSN:1015-6305
Container-title:Brain Pathology
language:en
Short-container-title:Brain Pathology

Author:

Bolko Loïs¹^ORCID,Jiang Wei²³,Tawara Nozomu²³,Landon‐Cardinal Océane⁴⁵,Anquetil Céline²³,Benveniste Olivier²³,Allenbach Yves²³

Affiliation:

1. Division of Rheumatology Hopital Maison Blanche Reims France

2. Department of Internal Medicine and Clinical Immunlogy Sorbonne UniversitéPitié‐Salpêtrière University Hospital Paris France

3. Centre de Recherche en Myologie UMRS974 Institut National de la Santé et de la Recherche Médicale Association Institut de Myologie Sorbonne Université Paris France

4. Division of Rheumatology Centre hospitalier de l'Université de Montréal (CHUM)CHUM Research Center Montréal QC Canada

5. Department of Medicine Université de Montréal Montréal QC Canada

Publisher

Wiley

Subject

Clinical Neurology,Pathology and Forensic Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bpa.12955

Reference126 articles.

1. Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies

2. The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis

3. Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases

4. Antisynthetase syndrome pathogenesis: knowledge and uncertainties

5. Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein kinase R is highly expressed in dermatomyositis and promotes interferon-beta-induced muscle damage;Annals of the Rheumatic Diseases;2024-09-05

2. A Novel Treatment for Skin Manifestations in Dermatomyositis: A Case Report;Cureus;2024-08-12

3. A complex presentation of anti-NXP2 antibody positive inflammatory myositis with peripheral neuropathy;Medical Reports;2024-08

4. Personalised medicine in juvenile dermatomyositis: From novel insights in disease mechanisms to changes in clinical practice;Best Practice & Research Clinical Rheumatology;2024-08

5. Differentiating idiopathic inflammatory myopathies by automated morphometric analysis of MHC‐1, MHC‐2 and ICAM‐1 in muscle tissue;Neuropathology and Applied Neurobiology;2024-07-19